Natus Medical Incorporated
1501 Industrial Road
San Carlos
California
94070-4111
United States
Tel: 650-802-0400-or-800-255-3901
Fax: 650-802-0401
Website: http://www.natus.com/
231 articles about Natus Medical Incorporated
-
Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS
1/18/2023
Natus Medical Incorporated announced the closing of its acquisition of Micromed Holding SAS, a global provider of neurophysiology solutions.
-
Natus Medical Incorporated to Acquire Micromed Holding SAS
12/2/2022
Natus Medical Incorporated has entered into a definitive agreement to acquire Micromed Holding SAS, a global provider of neurophysiology solutions.
-
ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value
7/21/2022
Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), announced today that the MED Platform II fund of ArchiMed (“ArchiMed”), a leading investment firm focused exclusively on the healthcare industry, completed the acquisition of Natus.
-
Natus Medical Announces First Quarter 2022 Financial Results
5/5/2022
Natus Medical Incorporated announced financial results for the three months ended March 31, 2022.
-
Natus Medical Incorporated to be acquired by ArchiMed Group for $33.50 per share in cash
4/18/2022
Natus Medical Incorporated announced that it has entered into a definitive agreement to be acquired by an affiliate of ArchiMed, a leading investment firm focused exclusively on the healthcare industry for approximately $1.2 billion.
-
Natus Medical to Hold 2022 First Quarter Financial Results Conference Call on May 6th
4/1/2022
Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced that the Company will release its 2022 first quarter financial results after the close of the market on Thursday, May 5th.
-
Natus Medical Announces Fourth Quarter 2021 Financial Results
2/24/2022
Natus Medical Incorporated announced financial results for the three months and full year ended December 31, 2021.
-
Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue
1/10/2022
Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced preliminary 2021 fourth quarter and full year revenue.
-
Natus to Participate in the 24th Annual Needham Virtual Growth Conference
1/7/2022
Natus Medical Incorporated announced that Thomas J. Sullivan, President and Chief Executive Officer, and Drew Davies, Executive Vice President and Chief Financial Officer, will be presenting at the 24th Annual Needham Virtual Growth Conference from 2:00 PM to 2:40 PM ET on Friday, January 14th.
-
Natus Medical to Hold 2021 Fourth Quarter Financial Results Conference Call on February 25th
1/3/2022
Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2021 fourth quarter financial results after the close of the market on Thursday, February 24th.
-
Natus Medical Announces Executive Transition
12/17/2021
Natus Medical Incorporated announced the appointment of Thomas J. Sullivan as President & Chief Executive Officer effective December 27, 2021 and a focus on long-term growth.
-
Natus Medical Announces Third Quarter 2021 Financial Results
11/4/2021
Natus Medical Incorporated today announced financial results for the three and nine months ended September 30, 2021.
-
Natus Medical Board of Directors Strengthens Governance and Focuses on Growth
10/14/2021
Natus Medical Incorporated announced today that the Company’s Board of Directors established an Environmental, Social, and Governance (ESG) committee and transitioned the role of the Quality & Compliance Committee to the Innovation & Quality committee on September 30th, 2021.
-
Natus Medical to Hold 2021 Third Quarter Financial Results Conference Call on November 5th
10/1/2021
Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced that the Company will release its 2021 third quarter financial results after the close of the market on Thursday, November 4th.
-
Bryant M. Moore, Ph.D. and Eric J. Guerin Appointed to Natus Board of Directors
8/18/2021
Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced the appointments of Bryant M. Moore, Ph.D. and Eric J. Guerin to the Company's Board of Directors.
-
Natus Medical Announces Second Quarter 2021 Financial Results
8/5/2021
Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced financial results for the three and six months ended June 30, 2021.
-
First Case Performed Using Natus XactTrode™ Subdural ElectrodesLaunch to US Market of XactTrodes for Epilepsy Surgical Monitoring
8/3/2021
Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, is pleased to announce the completion of the first successfully performed clinical case using Natus’ newly launched XactTrode™ family of platinum subdural electrodes.
-
Natus Medical to Hold 2021 Second Quarter Financial Results Conference Call on August 6th
7/1/2021
Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2021 second quarter financial results after the close of the market on Thursday, August 5th
-
Natus Chairperson Dr. Barbara Paul Retires; Board Elects Current Board Member Joshua Levine as Chairperson
6/28/2021
Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced Dr. Barbara Paul, the Chairperson of the Board of Directors will retire from the Board effective June 30, 2021.
-
Natus Medical Announces First Quarter 2021 Financial Results
5/6/2021
Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced financial results for the three months ended March 31, 2021.